| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/10/2005 | CN1652789A Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
| 08/10/2005 | CN1652788A Method of treating diabetes |
| 08/10/2005 | CN1652787A Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 08/10/2005 | CN1652786A Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 08/10/2005 | CN1652784A Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 08/10/2005 | CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors |
| 08/10/2005 | CN1652777A Combination of organic compounds |
| 08/10/2005 | CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/10/2005 | CN1652774A Use of valsartan or its metabolite to inhibit platelet aggregation |
| 08/10/2005 | CN1652772A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-dione: methods of using and compositions thereof |
| 08/10/2005 | CN1652769A Phosphate prodrugs of fluorooxindoles |
| 08/10/2005 | CN1652768A 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replaceme |
| 08/10/2005 | CN1652764A TGF-alpha expression inhibitors |
| 08/10/2005 | CN1652761A Preventive or therapeutic agent for kidney disease |
| 08/10/2005 | CN1652759A Small molecule entry inhibitors |
| 08/10/2005 | CN1652757A Use of EDG receptor binding agents in cancer |
| 08/10/2005 | CN1652754A Tasted masked veterinary solid compositions |
| 08/10/2005 | CN1652698A Method and dietary composition for improving lipid digestibility |
| 08/10/2005 | CN1652697A Method and dietary composition for improving fat digestibility |
| 08/10/2005 | CN1652696A Method of improving absorption of vitamin E by a pet animal |
| 08/10/2005 | CN1652695A Method of improving growth performance of animal |
| 08/10/2005 | CN1651431A Inhibitors of alpha L beta 2 mediated cell adhesion |
| 08/10/2005 | CN1651430A Synthesis method of saijiabin, its racemate and S-configuration, and preparation method of its amorphous powder |
| 08/10/2005 | CN1651087A Combination of organic compounds |
| 08/10/2005 | CN1651078A Medicinal composition for anti tumour and antisenility |
| 08/10/2005 | CN1651071A CD154 blockade therapy for therapeutic protein inhibitor syndrome |
| 08/10/2005 | CN1651070A Health care product having immune regulating and antimutation action |
| 08/10/2005 | CN1651063A Redy preparation Chinese medicine for treating kinetic fatigue and chronic fatigue syndrome |
| 08/10/2005 | CN1651055A Natural life beneficial Chinese medicine |
| 08/10/2005 | CN1651001A Ready prepared Chinese medicine for anti fatigue- and increasitg body energy |
| 08/10/2005 | CN1650975A Preparation method of compound peach blossom deea tortoise life nourishing agent |
| 08/10/2005 | CN1650963A Preparation method of sarcandra capsule |
| 08/10/2005 | CN1650930A Oral agent for relieving summer heal and its preparation method |
| 08/10/2005 | CN1214044C ErdB3 antibodies |
| 08/10/2005 | CN1214042C Production process for intravenous immune serum globulin and resultant product |
| 08/10/2005 | CN1214039C 3-nitrogen-6,7-dioxygen steroids and uses thereof |
| 08/10/2005 | CN1214038C 9alpha-chloro-6alpha-fluoro-17alpha-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl proup |
| 08/10/2005 | CN1214030C Prodrugs of imidazopyridine derivatives, medine containing same and use |
| 08/10/2005 | CN1214026C Indol-3-yl derivatives |
| 08/10/2005 | CN1214025C Sodium channel modulators derived from 2-piperidylimidazoles |
| 08/10/2005 | CN1214017C 四唑衍生物 Tetrazole derivatives |
| 08/10/2005 | CN1214011C Meta-azacyclic amino benzoic acid compound and derivatives thereof being integrin antagonists |
| 08/10/2005 | CN1214008C Therapeutic biaryl derivatives |
| 08/10/2005 | CN1213999C Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
| 08/10/2005 | CN1213752C Treating allergic and inflammatory diseases |
| 08/10/2005 | CN1213744C Remedies |
| 08/10/2005 | CN1213737C Oral controlled release formulations |
| 08/10/2005 | CN1213726C Resorcinol compsn. |
| 08/09/2005 | US6927317 Modulating ramp activity |
| 08/09/2005 | US6927303 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 08/09/2005 | US6927300 Process for the preparation of Latanoprost |
| 08/09/2005 | US6927238 Lipoxin analogs; antiinflammatory activity |
| 08/09/2005 | US6927234 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity |
| 08/09/2005 | US6927232 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 08/09/2005 | US6927231 and stress-related degenerative processes associated with aging or diseases such as cancer, neurodegenerative disease or dysregulation of redox-regulated physiological processes, indicated by prooxidative shift in plasma thiol/disulfide redox state |
| 08/09/2005 | US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation |
| 08/09/2005 | US6927227 Heterocyclic containing biphenyl aP2 inhibitors and method |
| 08/09/2005 | US6927224 Anticancer agents; osteoporosis |
| 08/09/2005 | US6927222 Compounds |
| 08/09/2005 | US6927220 Bicyclic-substituted 4-amino-pyridopyrimidine derivatives |
| 08/09/2005 | US6927219 Secondary amides such as N-Adamantan-1-methyl-2-chloro-5-(3,5-dioxo-4,5-dihydro-3H- (1,2,4)triazin-2-yl)-benzamide used as antagonists for biological receptors; antiinflammatiory, anticarcinogenic or antiischemic agents |
| 08/09/2005 | US6927218 Aryl N-cyanoguanidines and methods related thereto |
| 08/09/2005 | US6927211 Method for reducing toxicity of combined chemotherapies |
| 08/09/2005 | US6927054 Peptide for use in the diagnosis, prevention, and treatment of inflammation, cancer, arteriosclerosis and degenerative defects |
| 08/09/2005 | US6926907 Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| 08/09/2005 | US6926898 Albumin fusion proteins |
| 08/09/2005 | US6926178 Valve with a two-component seal |
| 08/09/2005 | CA2310627C Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 08/09/2005 | CA2249330C Method of treating heart failure with endothelin antagonists |
| 08/09/2005 | CA2231700C Prodrugs of aspartyl protease inhibitors |
| 08/09/2005 | CA2178603C Transdermal therapeutical system for preventing poisoning by organophosphoric neurotoxins that consists of a combination of active substances including a parasympathomimetric and a parasympatholytic agent |
| 08/09/2005 | CA2139865C Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases |
| 08/09/2005 | CA2136952C Preparation for activation of natural killer cells (nk-cells), said preparation containing interferon- and histamine, serotonin, amines or substances with corresponding receptor activity |
| 08/09/2005 | CA2095659C Heteroatoms-containing tricyclic compounds |
| 08/04/2005 | WO2005070923A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 08/04/2005 | WO2005070459A1 Method of continuing expression of vector repeatedly administered |
| 08/04/2005 | WO2005069771A2 Small molecule antagonists of bcl-2 family proteins |
| 08/04/2005 | WO2004016726A9 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 08/04/2005 | WO2004007457A3 Substituted benzylamine derivatives and methods of use |
| 08/04/2005 | US20050172353 Expression vector for improving heterologous gene expression; herbicide resistant crop plants |
| 08/04/2005 | US20050171354 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for prophylaxis of cardiovascular disorders |
| 08/04/2005 | US20050171353 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5) |
| 08/04/2005 | US20050171352 Process for the preparation of 4-(8-chloro-5 6-dihydro-11h-benzo-(5 6)-cyclohepta-(1 2b)-pyridin-11-ylidene-1-piperidiniecarboxylic acid ethyl ester (loratadine) |
| 08/04/2005 | US20050171350 Benzhydryl derivatives |
| 08/04/2005 | US20050171347 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/04/2005 | US20050171346 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections |
| 08/04/2005 | US20050171345 Pteridine compounds for the treatment of psoriasis |
| 08/04/2005 | US20050171338 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 08/04/2005 | US20050171286 Copolymer-1 improvements in compositions of copolymers |
| 08/04/2005 | US20050171211 vanillylalkyl-(methyl)oxyalkyl-carbonyl derivatives; tyrosinase inhibitor; antioxidant; foods, drugs, cosmetics; reduce lipid peroxide via oxidation; prevent speckles and spots; less toxicity |
| 08/04/2005 | US20050171204 2S)-3-(4-{2-[(Cyclohexylmethyl)(heptyl)amino]-2-oxoethoxy}phenyl)-2-ethoxypropanoic acid; treating lipid disorders (dyslipidemias), insulin resistance |
| 08/04/2005 | US20050171196 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same |
| 08/04/2005 | US20050171186 3-(1',2'-Dihydro-2'-thioxospiro[cyclohexane-1,3'-[3H]indol]-5'-yl)benzonitrile; 5'-(5-Cyano-1-methyl-1H-pyrrol-2-yl)spiro[cyclohexane-1,3'-[3H]indol]-2'-ylidenecyanamide; progesterone receptor agonist; mixture with estrone (estrogen); hormone replacement therapy, contraception; anticarcinogenic |
| 08/04/2005 | US20050171183 Indole-type inhibitors of p38 kinase |
| 08/04/2005 | US20050171178 Exo-1-methyl-1H-imidazole-4-sulfonic acid {3-[6-ethyl-3-(2-hydroxy-indan-2-ylmethyl)-3-aza-bicyclo[3.1.0]hex-6-yl]-phenyl}-amide; opioid receptors (mu, kappa and delta) antagonists; not substrate of the variable enzyme CYP2D6; addiction to an opiates, alcohol; obesity |
| 08/04/2005 | US20050171175 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
| 08/04/2005 | US20050171174 Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 08/04/2005 | US20050171173 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors |
| 08/04/2005 | US20050171163 MCP-1 receptor antagonists and methods of use thereof |
| 08/04/2005 | US20050171153 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases |